Logo

Sugen Uses Pangea's Tools To Reduce Redundancies

Dec 03, 1999
Premium

OAKLAND, Calif.--Sugen, a small molecule drug-discovery company wholly owned by Pharmacia and Upjohn, has licensed Pangea Systems' proprietary Clustering and Alignment Tools. Greg Plowman, Sugen's vice-president of molecular biology, said that the performance of Pangea's clustering tool on multiprocessor machines would allow Sugen to reduce the redundancies in its large sequence databases.

Filed under

Informatics
Breaking News
The Scan

For Those Thick Tiger Stripes

Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports.

High GABA Tomatoes

The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan.

Approach for Inclusivity and Diversity

A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos."

Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation

In Science this week: study of how tumors evade the adaptive immune system, and more.